Compass Therapeutics, Inc. Share Price
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
01:30:00 22/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.400 USD | +1.69% |
|
+6.67% | -55.31% |
| Market Cap | 43Cr 37Cr 35Cr 32Cr 60Cr 4.14TCr 60Cr 409.28Cr 159.61Cr 2.08TCr 162.29Cr 158.76Cr 6.87TCr | P/E 2026 * |
-4.79x | P/E 2027 * | -4.34x |
|---|---|---|---|---|---|
| Enterprise Value | 28Cr 24Cr 23Cr 21Cr 39Cr 2.7TCr 39Cr 267.24Cr 104.21Cr 1.36TCr 105.97Cr 103.66Cr 4.49TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 13.4x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compass Therapeutics, Inc.
| 1 day | +1.69% | ||
| 1 week | +6.67% | ||
| Current month | +25.65% | ||
| 1 month | +14.29% | ||
| 3 months | +24.35% | ||
| 6 months | -61.10% | ||
| Current year | -55.31% |
| 1 week | 2.2 |  | 2.52 |
| 1 month | 1.85 | | 2.52 |
| Current year | 1.61 | | 6.88 |
| 1 year | 1.61 | | 6.88 |
| 3 years | 0.76 | | 6.88 |
| 5 years | 0.76 | | 6.88 |
| 10 years | 0.76 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 28/05/2024 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 09/12/2024 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 01/01/2014 |
Phil Ferneau
BRD | Director/Board Member | 64 | 01/01/2015 |
Carl Gordon
CHM | Chairman | 61 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/02/26 | Tax | Chief Executive Officer | 36,687 | 0.0206% | ||
| 09/01/26 | Tax | Chief Executive Officer | 46,777 | 0.0263% | ||
| 02/01/26 | Free | Director | 90,000 | 0.0506% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.69% | +6.67% | -14.29% | +1.69% | 43Cr | |
| -3.00% | +2.27% | +77.60% | +109.33% | 7.21TCr | |
| +1.90% | +23.53% | +56.60% | +97.76% | 6.59TCr | |
| +5.12% | +25.22% | +5.24% | -0.82% | 2.93TCr | |
| +0.55% | +1.64% | -5.15% | +471.68% | 2.75TCr | |
| +2.74% | +12.98% | +62.84% | +28.14% | 2.67TCr | |
| +0.47% | +6.12% | +36.66% | -13.79% | 2.01TCr | |
| +1.82% | -6.67% | +247.46% | +393.10% | 1.82TCr | |
| +0.94% | +3.36% | +18.55% | +532.94% | 1.64TCr | |
| +0.73% | +5.54% | +39.71% | +153.07% | 1.34TCr | |
| Average | +1.30% | +8.19% | +52.52% | +177.31% | 2.9TCr | |
| Weighted average by Cap. | +0.74% | +9.48% | +58.94% | +157.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 2.24Cr 1.92Cr 1.79Cr 1.64Cr 3.08Cr 214.26Cr 3.12Cr 21Cr 8.27Cr 107.63Cr 8.41Cr 8.23Cr 356Cr |
| Net income | -9.4Cr -8.06Cr -7.54Cr -6.9Cr -13Cr -899.79Cr -13Cr -89Cr -35Cr -452.01Cr -35Cr -35Cr -1.5TCr | -11Cr -9.41Cr -8.8Cr -8.06Cr -15Cr -1.05TCr -15Cr -104Cr -41Cr -527.88Cr -41Cr -40Cr -1.75TCr |
| Net Debt | -15Cr -13Cr -12Cr -11Cr -21Cr -1.44TCr -21Cr -142.04Cr -55Cr -720.96Cr -56Cr -55Cr -2.38TCr | -13Cr -11Cr -11Cr -9.76Cr -18Cr -1.27TCr -19Cr -125.94Cr -49Cr -639.25Cr -50Cr -49Cr -2.11TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | $2.400 | +1.69% | 20,32,331 |
| 20/26/20 | $2.360 | -4.84% | 21,79,350 |
| 19/26/19 | $2.480 | +3.77% | 39,03,263 |
| 18/26/18 | $2.390 | +3.46% | 29,34,326 |
| 17/26/17 | $2.310 | +2.67% | 23,69,229 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
